9.54
price down icon5.82%   -0.59
after-market After Hours: 9.54
loading

Avalo Therapeutics Inc Stock (AVTX) Forecast

The Avalo Therapeutics Inc (AVTX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $3.216, representing a -66.29% decrease from the current price of $9.54. The highest analyst price target is $2.905, and the lowest is $3.5269.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month AVTX Price Target
Average 5.2732 (-44.72% Downside)
loading

Is Avalo Therapeutics Inc (AVTX) A Buy Now?

Oscillators
Name Value Action
RSI(14) 50.88 Neutral
STOCH(9,6) 58.56 Neutral
STOCHRSI(14) 37.17 Neutral
MACD(12,26) 0.1061 Buy
ADX(14) 12.65 Neutral
William %R -45.94 Neutral
CCI(14) 44.04 Neutral
Buy: 1 Sell: 0 Neutral: 6
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
9.5892
Sell
9.5666
Sell
MA20
9.4748
Buy
9.4458
Buy
MA50
9.3375
Buy
9.66
Sell
MA100
10.65
Sell
9.8718
Sell
MA200
9.5053
Buy
8.6116
Buy
Buy: 5 Sell: 5 Neutral: 0
Summary: Neutral
According to our latest analysis, AVTX could be considered a Neutral, with 17 technical analysis indicators signaling 6 Buy signals, 5 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on AVTX, as the market is likely to remain volatile in the near term.
  1. RSI (Relative Strength Index): The RSI(14) value of 50.88 indicates that AVTX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 58.56 indicates that AVTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 37.17 indicates that AVTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 12.65 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 44.04 indicates that AVTX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term AVTX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Avalo Therapeutics Inc financial reports and earnings history, Avalo Therapeutics Inc (AVTX) stock could reach $10.77 by 2030, $62.12 by 2040 and $85.19 by 2050. See the projected annual prices until 2050 of the Avalo Therapeutics Inc stock below:

  • Avalo Therapeutics Inc (AVTX) is expected to reach an average price of $36.39 in 2035, with a high prediction of $36.09 and a low estimate of $36.41. This indicates an $281.47% rise from the last recorded price of $9.54.
  • Avalo Therapeutics Inc (AVTX) stock is projected to chart a bullish course in 2040, with an average price target of $63.03, representing an $560.68% surge from its current level. The forecast ranges from a conservative $61.70 to a sky-high $62.12.
  • Our analysts predict Avalo Therapeutics Inc (AVTX) to jump 426.40% by 2045, soaring from $47.78 to an average price of $50.22, potentially reaching $49.82. While $47.78 is the low estimate, the potential upside is significant.
  • Avalo Therapeutics Inc (AVTX) stock is expected to climb by 2050, reaching an average of $85.30, a $794.18% jump from its current level. However, a wide range of estimates exists, with high and low targets of $85.19 and $85.32, respectively, highlighting the market's uncertainty.

Avalo Therapeutics Inc Stock (AVTX) Year by Year Forecast

Avalo Therapeutics Inc Stock (AVTX) Price Forecast for 2024

Our forecast for AVTX stock price in 2024 now indicates an average price target of $17.50 with a high forecast of $34.46 and a low forecast of $0.535. The average prediction reflects an increase of +83.41% from the last recorded price of $9.54.
Month Average Low High Change from today's price
November, 2024 $3.2534 $3.5269 $2.905 -65.90%
December, 2024 $3.878 $2.9835 $3.0203 -59.35%

Avalo Therapeutics Inc Stock (AVTX) Price Forecast for 2025

Avalo Therapeutics Inc Stock (AVTX) is expected to reach an average price of $6.0099 in 2025, with a high prediction of $7.563 and a low estimate of $4.4568. This indicates an -37.00% fall from the last recorded price of $9.54.
Month Average Low High Change from today's price
January, 2025 $8.5242 $4.584 $7.563 -10.65%
February, 2025 $6.9059 $7.7747 $7.3298 -27.61%
March, 2025 $5.2288 $5.8852 $5.0624 -45.19%
April, 2025 $7.445 $5.1921 $6.535 -21.96%
May, 2025 $6.118 $6.1947 $6.6283 -35.87%
June, 2025 $6.6209 $6.1244 $5.9244 -30.60%
July, 2025 $5.2771 $5.2871 $7.0584 -44.68%
August, 2025 $4.62 $4.4568 $4.3236 -51.57%
September, 2025 $4.573 $4.998 $4.7824 -52.07%
October, 2025 $5.1291 $4.9994 $4.8491 -46.24%
November, 2025 $5.9971 $5.1156 $5.8521 -37.14%
December, 2025 $7.2383 $6.4753 $6.8083 -24.13%

Avalo Therapeutics Inc Stock (AVTX) Price Forecast for 2026

The predicted value for Avalo Therapeutics Inc (AVTX) in 2026 is set at an average of $4.4665. Estimates vary from a peak of $8.6729 to a trough of $0.26, indicating an -53.18% surge from the present price of $9.54.
Month Average Low High Change from today's price
January, 2026 $7.8012 $7.2915 $7.4012 -18.23%
February, 2026 $6.5591 $6.8641 $7.6477 -31.25%
March, 2026 $5.9171 $6.6074 $6.6439 -37.98%
April, 2026 $5.2133 $6.2288 $6.3068 -45.35%
May, 2026 $8.6541 $5.2464 $8.625 -9.29%
June, 2026 $8.6642 $8.6515 $8.6729 -9.18%
July, 2026 $8.5639 $8.5693 $8.6237 -10.23%
August, 2026 $8.3876 $8.3883 $8.5146 -12.08%
September, 2026 $8.215 $8.234 $8.3119 -13.89%
October, 2026 $8.0894 $8.0919 $8.1788 -15.21%
November, 2026 $7.9703 $7.997 $8.0461 -16.45%
December, 2026 $3.6365 $0.26 $7.9335 -61.88%

Avalo Therapeutics Inc Stock (AVTX) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Avalo Therapeutics Inc (AVTX) is $13.58, with a high forecast of $27.05 and a low forecast of $0.0982. This indicates an +42.31% increase from the last price of $9.54.
Month Average Low High Change from today's price
January, 2027 $3.0195 $3.3629 $2.9795 -68.35%
February, 2027 $3.1324 $3.2127 $3.1375 -67.17%
March, 2027 $9.0314 $2.8053 $27.05 -5.33%
April, 2027 $9.8985 $3.7682 $11.49 +3.76%
May, 2027 $1.3071 $0.2529 $9.9152 -86.30%
June, 2027 $3.1147 $0.1059 $4.0747 -67.35%
July, 2027 $1.0312 $0.0982 $3.4282 -89.19%
August, 2027 $2.4171 $3.7981 $2.4906 -74.66%
September, 2027 $13.30 $5.4635 $12.56 +39.37%
October, 2027 $14.17 $13.62 $12.80 +48.51%
November, 2027 $15.62 $15.36 $14.80 +63.76%
December, 2027 $15.58 $14.73 $14.80 +63.36%

Avalo Therapeutics Inc Stock (AVTX) Price Forecast for 2028

In 2028, Avalo Therapeutics Inc (AVTX) is projected to reach an average price of $17.00, with a high projection of $19.09 and a low estimate of $14.91. This indicates an +78.19% rise from the last price of $9.54.
Month Average Low High Change from today's price
January, 2028 $19.15 $16.25 $17.84 +100.73%
February, 2028 $18.50 $19.23 $19.09 +93.96%
March, 2028 $16.46 $17.11 $17.28 +72.51%
April, 2028 $17.64 $16.38 $17.40 +84.94%
May, 2028 $17.02 $17.13 $17.64 +78.36%
June, 2028 $17.37 $16.95 $16.78 +82.09%
July, 2028 $15.91 $17.11 $17.74 +66.75%
August, 2028 $15.04 $14.91 $15.60 +57.65%
September, 2028 $14.85 $15.27 $15.11 +55.62%
October, 2028 $15.21 $15.20 $14.97 +59.45%
November, 2028 $15.94 $15.13 $15.79 +67.08%
December, 2028 $16.72 $16.38 $16.36 +75.26%

Avalo Therapeutics Inc Stock (AVTX) Price Forecast for 2029

The 2029 price forecast for Avalo Therapeutics Inc Stock (AVTX) is $12.91 on average, with a high prediction of $17.65 and a low estimate of $8.1801. This represents an +35.37% increase from the previous price of $9.54.
Month Average Low High Change from today's price
January, 2029 $17.41 $17.01 $17.01 +82.52%
February, 2029 $16.02 $16.33 $17.22 +67.96%
March, 2029 $15.23 $16.03 $16.00 +59.69%
April, 2029 $14.32 $15.48 $15.51 +50.11%
May, 2029 $17.64 $14.34 $17.65 +84.91%
June, 2029 $17.50 $17.50 $17.55 +83.47%
July, 2029 $17.28 $17.29 $17.43 +81.18%
August, 2029 $16.90 $16.90 $17.21 +77.11%
September, 2029 $16.62 $16.63 $16.78 +74.24%
October, 2029 $16.27 $16.27 $16.53 +70.51%
November, 2029 $16.00 $16.03 $16.19 +67.72%
December, 2029 $10.05 $8.1801 $15.93 +5.31%

Avalo Therapeutics Inc Stock (AVTX) Price Forecast for 2030

Avalo Therapeutics Inc Stock (AVTX) is expected to reach an average price of $13.51 in 2030, with a high forecast of $26.69 and a low forecast of $0.3305. This signifies an +41.60% surge from the last price of $9.54.
Month Average Low High Change from today's price
January, 2030 $10.72 $11.10 $10.77 +12.36%
February, 2030 $10.68 $10.80 $10.76 +12.00%
March, 2030 $6.9393 $10.21 $19.65 -27.26%
April, 2030 $1.4234 $0.4872 $7.7328 -85.08%
May, 2030 $11.54 $0.3305 $10.70 +20.96%
June, 2030 $9.7782 $12.88 $11.21 +2.50%
July, 2030 $13.55 $10.87 $12.05 +42.00%
August, 2030 $14.79 $16.28 $14.90 +54.99%
September, 2030 $26.12 $17.80 $24.78 +173.79%
October, 2030 $26.21 $25.76 $24.83 +174.69%
November, 2030 $27.51 $27.36 $26.69 +188.40%
December, 2030 $24.78 $26.47 $26.60 +159.71%
$23.53
price down icon 0.76%
$358.22
price up icon 1.10%
$58.29
price up icon 2.57%
$236.10
price down icon 1.37%
$120.52
price up icon 1.82%
$536.70
price up icon 1.79%
Cap:     |  Volume (24h):